Orphan Drugs
2026-05-17 · Department of Health and Social Care · HL202 · Official question
Question
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 11 March (HL15195), what assessment they have made of the suitability of conventional cost-effectiveness assessments for medicines where structural evidence constraints a
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service on whether new medicines should be routinely funded by the NHS based on an assessment of clinical and cost effe...